Hospital-level care at home for people with advanced liver disease
Tests a home-based hospital care program in adults with advanced cirrhosis.
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 21 Jul 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional
- Treatments tested
- Hepatology Home Hospital
- Record updated
- 7 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cirrhosis (scarred liver) who come to the emergency department or general medicine ward. It tests hospital-level care given at home.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Cirrhosis shown by tissue sample, imaging and/or elastography (a liver stiffness scan). People must also have one of these: fluid in the belly needing diuretics or repeated large fluid drainage; fluid in the chest from liver disease needing diuretics; or confusion from liver disease (hepatic encephalopathy) needing medicine.
- Biomarker or test result
- MELD score (a liver disease severity score) must not be above 20.
Main reasons for not taking part
- Past solid organ transplant
- On hemodialysis
- Score below 10 on the Simplified Animal Naming Test (S-ANT1)
- Current hospital stay for serious stomach or gut bleeding, or for alcohol withdrawal
- Needing controlled substances given routinely
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
- Patients must have one of the following:; Ascites (requiring diuretics or serial large volume paracenteses); Hepatic hydrothorax (requiring diuretics); Hepatic encephalopathy (requiring medications)
Who cannot take part
- History of solid organ transplantation
- Current admission for hemodynamically significant GI bleeding or alcohol withdrawal
- On hemodialysis
- MELD score > 20
- Score <10 on Simplified Animal Naming Test (S-ANT1)
- Require routine administration of controlled substances
- Those deemed ineligible based on the MGH Home Hospital, inpatient medicine or hepatology clinician evaluation
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Will Munroe, BATaking people
About the trial
What the trial wants to find out
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
The group in the trial
- Hepatology Hospital at HomeTreatment being tested
Patients with advanced liver disease receive hospital-level care in the home setting
Treatment: Hepatology Home Hospital
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
- Plain-language title
- Hospital-level care at home for people with advanced liver diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 7 October 2026